HJ Science Co., Ltd.

HK$31.96As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6132Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$2.352B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$35
10.92%
35.48%
Hold 5|2|2|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.57
0.56
0.60
0.58
4.98%
6.55%
6.48%
0.82%
Revenue¥M
256.8
265.8
264.2
257.1
8.08%
14.33%
10.06%
2.11%
Peers (US$300.0M)
Cap (US$)
PE
301.1M
76.93x
Capital
TTM
5Y
10Y
Leveragex
0.133
0.021
0.015
EBIT/Intx
1.965
0.821
0.627
Own earn%
(714.65)
56.57
57.10
Sh yield%
24.85
51.07
48.64
Owners
Insiders/Inst%
10.31
31.80
Short interest%
0.95
SBC / revenue%
0.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
27–34
$1 testx
—
Incr. ROIC%
51